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This journal is ª The Royal Society ofMicromotor-based lab-on-chip immunoassays†
Miguel Garc´ıa,‡ab Jahir Orozco,‡a Maria Guix,‡ac Wei Gao,a
Sirilak Sattayasamitsathit,a Alberto Escarpa,b Arben Merkoçic and Joseph Wang*a
Here we describe the ﬁrst example of using self-propelled antibody-functionalized synthetic catalytic
microengines for capturing and transporting target proteins between the diﬀerent reservoirs of a lab-
on-a-chip (LOC) device. A new catalytic polymer/Ni/Pt microtube engine, containing carboxy moieties
on its mixed poly(3,4-ethylenedioxythiophene) (PEDOT)/COOH–PEDOT polymeric outermost layer, is
further functionalized with the antibody receptor to selectively recognize and capture the target
protein. The new motor-based microchip immunoassay operations are carried out without any bulk
ﬂuid ﬂow, replacing the common washing steps in antibody-based protein bioassays with the active
transport of the captured protein throughout the diﬀerent reservoirs, where each step of the
immunoassay takes place. A ﬁrst microchip format involving an ‘on-the-ﬂy’ double-antibody sandwich
assay (DASA) is used for demonstrating the selective capture of the target protein, in the presence of
excess of non-target proteins. A secondary antibody tagged with a polymeric-sphere tracer allows the
direct visualization of the binding events. In a second approach the immuno-nanomotor captures and
transports the microsphere-tagged antigen through a microchannel network. An anti-protein-A
modiﬁed microengine is ﬁnally used to demonstrate the selective capture, transport and convenient
label-free optical detection of a Staphylococcus aureus target bacteria (containing proteinA in its cell
wall) in the presence of a large excess of non-target (Saccharomyces cerevisiae) cells. The resulting
nanomotor-based microchip immunoassay oﬀers considerable potential for diverse applications in
clinical diagnostics, environmental and security monitoring ﬁelds.Introduction
The reliable identication, isolation and quantication of
proteins holds an enormous potential to satisfy the growing
demands in diverse elds, including medical diagnostics, food
safety, forensic analysis, environmental monitoring and bio-
defense applications.1 A wide variety of techniques are available
for protein detection and purication. Particularly attention has
been given to antibody-based standard ELISA protocols within
multiple well plates,2,3 although such assays oen require long
incubation times and multiple washing steps. Recent advances
in the eld of microanalytical systems have led to the develop-
ment of lab-on-a-chip (LOC) immunoassays, coupling the power
of microchip devices with the high specicity and sensitivity of
antigen–antibody interactions.4–8 Yet, new eﬃcient microchipy of California-San Diego, La Jolla, CA
emical Engineering, University of Alcala´,
ology, Campus University Auto´noma de
pain
tion (ESI) available. See DOI:
to this work.
Chemistry 2013immunoassays oﬀering direct, simple and rapid isolation of
target proteins are desired.
Here we present a novel ‘on-the-y’ microchip sandwich
immunoassay based on self-propelled antibody-functionalized
articial microtransporters able to perform each of the immu-
noassay steps in diﬀerent reservoirs and providing direct visu-
alization of the protein binding event. Biological motors and
related motion-driven processes have demonstrated the ability
to capture and transport target proteins along microtubule
tracks in microchip devices.9–11 One attractive example is a
kinesin-powered ‘smart dust’ sensing device, containing anti-
body-functionalized microtubules, where the antigen capture
and transport allow the replacement of the common washing
steps.11 Microtubule-based molecular shuttles, coupled to
kinesin-coated microchannel tracks, were also used for motion-
based protein sorting.9,10 However, practical utility of such
kinesin-based microchip immunoassays is hindered by the
limited operational stability and lifetime of biological motors in
engineering environments (associated with the rapid degrada-
tion of proteins outside biological environment) and by the
necessity of precongured microlithographic tracks to guide
their movement.9,11
The limitations of protein nanomotors have motivated the
present study in which self-propelled antibody-functionalized
articial microtransporters have been incorporated for the rstNanoscale, 2013, 5, 1325–1331 | 1325
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View Article Onlinetime into microchannel networks to create an advanced
autonomous microchip device that integrates the protein
capture, transport and detection operations within diﬀerent
separated zones. Synthetic catalytic nanomotors12–17 are highly
compatible with engineered microsystems and environments
and can thus be readily adapted to diﬀerent LOC formats.18
Non-functionalized nanowire and microtube motors were used
earlier for a guidedmovement and cargo-towing within complex
microchannel networks of microchip devices.19,20 Receptor-
functionalized articial nanomotors can oﬀer the selective
isolation of biological targets from raw physiological uids by
capturing and transporting them to a clean environment.21
While several self-propelled microtransporters have thus
recently been described for isolating diﬀerent biological
targets,22–25 there are no reports on the use of articial micro-
motors for antibody-based protein immunoassays and related
LOC protocols.
In the following sections we will demonstrate the rst
example of a LOC immunoassay based on the active transport of
antibody-functionalized synthetic micromotors (Fig. 1). As
illustrated in Fig. 1, A, a simplied preparation of the func-
tionalized microtransporters has been performed, relying on
the presence of carboxy-terminated outermost polymeric layerFig. 1 Schematic of the micromotor-based microchip immunoassay. Micro-
engine surface modiﬁcation (I): immobilization of anti-IgG on the COOH–
PEDOT:PEDOT microengine surface (A). Activation of the COOH groups through
EDC/NHS chemistry (1) and immobilization of the anti-IgG antibody on the active
moieties (2). Modiﬁcation of streptavidin-coated PP (B) with the biotinylated-anti-
IgG antibody (1) and IgG antigen (2). Micromotor-based microchip immunoassay
(II): in a DASA format, the anti-IgG-modiﬁed microengines are introduced into
reservoir A and guided towards reservoir B, where they navigate for 10 min in a
solution containing the target protein in the presence 10-fold non-target
proteins. The modiﬁed microengine with the target protein is conducted to a
third reservoir containing the tagged-PP. In a sphere tagged-antigen format, the
anti-IgG-modiﬁedmicroengines are introduced in reservoir A and guided towards
a reservoir B to pick-up the anti-IgG-modiﬁed PP and guided to reservoir C.
1326 | Nanoscale, 2013, 5, 1325–1331of the template-deposited polymer/Ni/Pt microtubes. The
resulting antibody-functionalized micromotors oﬀer an ‘on-the-
y’ capture and transport of the target antigen and, in a second
step, the pickup of a sphere-tagged secondary antibody, thus
demonstrating the eﬃciency of the diﬀerent conjugation events
held in each microchip reservoirs (Fig. 1, II le). Transport step
thus replaces the washing steps common in traditional double-
antibody sandwich assays (DASA), in a manner analogous to
kinesin-based ‘smart dust’ immunoassays.11 Tagging the
secondary antibody with the polymeric sphere oﬀers a conve-
nient direct visualization and detection of the immuno-
reactions. In a second approach, shown in Fig. 1, II (right), the
functionalized microengine captures and transports the
microsphere-tagged antigen through a microchannel network.
Therefore, convenient optical visualization of the detection and
transport events related to Staphylococcus aureus (S. aureus),
used as target bacteria which contains proteinA in its cell wall,
is also achieved by using anti-proteinA antibody-functionalized
microengines. Such marriage of immunoassays, self-propelled
articial microtransporters, motion-based direct detection and
microchip devices holds considerable promise for diverse
applications of lab-on-a-chip systems.Results and discussion
The new immuno-microtransporters were prepared by a
template-based electrodeposition of multilayer PEDOT:COOH–
PEDOT/Ni/Pt microtubes. Fig. 1 depicts the surface modica-
tion of the microengine (I) along with a schematic of the tubular
microtransporter and its corresponding cross-section. The
outermost polymeric layer is synthesized by co-electro-
polymerization of PEDOT:PEDOT–COOH (from an electro-
plating solution containing an equimolar mixture of the
monomers) followed by electrodeposition of the Ni and Pt
metallic layers (from a Pt–Ni mixture electroplating solution).
Whereas the inner Pt catalytic layer of the microtransporter is
essential for generating the oxygen bubble thrust, the inter-
mediate Ni layer is used for the magnetic guidance. The
outermost PEDOT:COOH–PEDOT layer serves to anchor the
antibody through the common carbodiimide (EDC)/N-hydroxy-
succinimide (NHS) chemistry (Fig. 1, A). Initial eﬀorts involving
a single COOH–PEDOT external layer resulted with numerous
COOH groups exposed on the microtransporter outermost
surface for subsequent functionalization step. However, the co-
deposition of a COOH–PEDOT:PEDOT was proved necessary to
avoid adherence of the PEDOT-based microtransporters to the
surface of a glass slide aer the antibody functionalization.
Electrochemical deposition conditions, such as composition of
the electroplating solutions, applied current, potential and
deposition time, were optimized (Table S1†; other optimal
conditions are described in the Experimental section). Carboxy
moieties from the electropolymerized PEDOT:COOH–PEDOT
external layer allow a direct functionalization of the resulting
microengines, thereby obviating the need for e-beam deposition
process of an outer gold layer and related clean room facilities.
Unlike other microtubular engines, whose speed is greatly
reduced aer the e-beam gold deposition and further surfaceThis journal is ª The Royal Society of Chemistry 2013
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View Article Onlinefunctionalization, the fast original speed of the COOH–
PEDOT:PEDOT/Ni/Pt microtransporters (400 mm s1) is not
aﬀected by this direct functionalization process. Furthermore,
eliminating the need for self-assembled monolayers of alka-
nethiols25,26 obviates potential poisoning of the inner Pt surface,
hence ensuring high catalytic activity and therefore the eﬃcient
microtransporters movement. It should be noted that unlike
earlier gold-based microengine functionalization schemes,
involving modication of half of the outer surface,25,26 the
present protocol allows the functionalization of the entire outer
surface, as the carboxy moieties cover the entire outermost
polymeric surface that will be coupled later to the antibody
receptor.
The resulting polymer/Ni/Pt microtransporters propel eﬃ-
ciently via the expulsion of oxygen bubbles generated by the
catalytic oxidation of hydrogen peroxide fuel at their inner Pt
layer.27,28 The template fabrication process results in 8 mm-long
microtubes, similar to the scale of the particle-microsphere tag,
which oﬀers a convenient real-time optical visualization of the
protein binding event. For example, the formation and move-
ment of the immuno-sandwich complex can be readily visual-
ized by tagging the secondary antibody with a microsphere
tracer. Fig. 1, II illustrates the micromotor-based microchip
immunoassay protein isolation protocol. All the capture-trans-
port-tag-transport steps involved in the immunoassay protocol
are thus carried out in the microuidic device, hence replacing
the capture-wash-tag-wash sequence common in conventional
DASA protocols.
The ability of the micromotor to travel within a pre-
determined path along the microchip channels is crucial for the
successful performance of the new LOC immunoassay protocol.
Fig. 2 and Video S1A† show the guided movement of the
unmodied polymer/Ni/Pt microengine within diﬀerent
sections of the LOC microchannel network containing a PBS
solution along with the H2O2 fuel and sodium cholate (NaCh)
surfactant. These images demonstrate the self-propelled
micromotor departing from the reservoir (a), crossing the
channel interconnecting reservoirs (b) and entering the T-shape
cross-section while swimming within this junction (c). The
generated oxygen bubbles are clearly noticeable during such
autonomous movement inside the microchip, as previously
reported for other microengines.20,23 As indicated from the
corresponding video, the microengine displays an eﬃcientFig. 2 Navigation of an unmodiﬁed COOH–PEDOT:PEDOT microengine within a
LOC device. Diﬀerent overlaid time lapse images (labeled as 1, 2, 3) of the
microengine leaving a reservoir (a), crossing the channel between two reservoirs
(b) and entering the T-shape cross-section (c). Arrows indicate the direction of the
movement.
This journal is ª The Royal Society of Chemistry 2013movement and advanced spatial motion control within the
narrow channels and the diﬀerent reservoirs in the microchip,
reecting the precise magnetic guidance associated with its
intermediate Ni layer. Such advanced guided motion and eﬃ-
cient propulsion within the complex microchannel network
meets the demands for the sandwich immunoassay and other
complex microchip operations.
Aer demonstrating the precise microengine movement
within the microchannel network, the microtransporters were
functionalized with the corresponding antibody receptors to
carry out the microchip immunoassays. In the rst bioassay
format, recognition of the target proteins was performed by
functionalizing the microtransporters with the antibody via
EDC/NHS chemistry (Fig. 1, IA), followed by the detection of the
target protein, which is conjugated to a secondary antibody
functionalized with streptavidin-coated polystyrene particles (S-
PP) (Fig. 1, IB). Therefore, the target binding event can be easily
visualized by optical microscopy, as the antibody-modied
microtransporter is eﬃciently picking-up the protein target-
conjugated secondary antibody-coated S-PP.
The microtransporter functionalization protocol was opti-
mized for eﬃcient protein–antibody interaction and locomo-
tion. A highly reproducible loading protocol was accomplished
by the systematic optimization of the experimental conditions
involved in the recognition and labeling steps. Several variables,
such as the amount of microtransporters, vortex speed (during
the antibody functionalization), concentration and incubation
time of the antibodies, were thus examined and optimized, as
summarized in Table S2†. The remaining amino moieties (aer
the modication) were blocked to minimize unspecic
adsorption of the target proteins.21
The specic capture of the target protein by the antibody-
modied microtransporters was rst examined by using the
LOC device. Fig. S2 and Video S1† illustrates an anti-IgG-
modied microtransporter leaving the microengines reservoir
of a linear-shaped chip (a), passing through the interconnection
channel (b) and arriving to the second reservoir (c), containing
the IgG/anti-IgG-modied biotinylated S-PP. The modied
microtransporter thus navigates into this second reservoir,
capturing the S-PP-tagged-IgG and leaving the reservoir (d).
Upon returning to the channel, the microengine-loaded withFig. 3 (a–d) Anti-IgG-modiﬁed microengines approaching, contacting and
capturing the IgG-antibody-modiﬁed particle complex. (e–g) Anti-IgG-modiﬁed
microengines approaching, contacting but not capturing the antibody-modiﬁed
particle (no IgG present; S-PP highlighted by an orange circle). It must be pointed
out that the anti-IgG-modiﬁed S-PP is not pre-incubated with the IgG. All negative
“controls” were performed on the surface of a glass slide.
Nanoscale, 2013, 5, 1325–1331 | 1327
Fig. 4 ‘On-the-ﬂy’ microchip sandwich immunoassay: capture and transport
proteins by using a DASA format. Microtransporters are modiﬁed with anti-IgG
antibody and placed in a reservoir; S-PP are modiﬁed with the anti-IgG antibody
and placed in another reservoir of the T-shaped LOC device; the free target IgG
protein along with a 10-fold excess (mg ml1) of BSA and lysozyme are added into
the third reservoir. A modiﬁed microtransporter moves from the modiﬁed-
microengine reservoir (1) to the one containing the protein mixture (2a) and after
10 min navigation is removed from the sample reservoir 3 (2b) to the anti-IgG S-
PP reservoir (4). In this last compartment the protein target, conﬁned on the
modiﬁed microtransporter, captures the modiﬁed particles (5a–c).
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View Article Onlinethe tagged analyte-captures and transport three additional S-PP-
tagged-proteins (e). This fact demonstrates the strong aﬃnity
of the antigen–antibody interaction and the high towing force of
the modied microtransporter. Fig. 3a–d and Video S3† shows
the pick-up and transport of a single antigen-conjugated
microsphere by the anti-IgG-modied microtransporter. This
gure illustrates the functionalized motor approaching (a),
contacting (b) and capturing and transporting (c) the antigen-
coated S-PP within the microchip reservoir, followed by its
entrance into a microchannel (d). The video shows the contin-
uous transport of the protein–particle complex while crossing
the entire reservoir (5 mm external diameter) at a speed of
44 mm s1, which is 50% slower compared to that observed
without the complex. In contrast, no pickup and transport are
observed in the control experiment of Fig. 3e–g using the anti-
body-modied microtransporter and antibody-modied
particle (in absence of the IgG antigen), despite the multiple
direct motor-particle contacts.
Other control experiments are illustrated in ESI, Fig. S2 and
Video S4† (negative control 2). The modied microengine is
shown rst contacting but not capturing the unmodied PP
(negative control 2; smaller size), while it is picking and trans-
porting the IgG-B–anti-IgG-modied S-PP complex (acting as
“positive control”, bigger size). These results demonstrate that
the antibody-modied microtransporters are able to specically
capture the target protein, indicating the great potential of
these immuno-microengines for transporting and isolating
proteins in a LOC device. The diﬀerent size of these tagged and
untagged particles (2.0 mm vs. 0.85 mm, respectively), allows a
clear optical real-time visualization and discrimination between
the “positive” and “negative controls” during the motor navi-
gation in one single experiment. The similar size scale of the
microengines and tags facilitates the clear visualization of the
binding events in real time (see Fig. 3 and S2 and Videos S2–
S4†). This selective and rapid capture mechanism is attributed
to the nearly instantaneous recognition of the proteins by the
antibody-modied microengine (Fig. 3a–c). The localized uid
convection associated with the microengine vortex eﬀect leads
to a fast protein binding event, as was demonstrated for other
bioisolation strategies based on such machines.23 Thus, unlike
common immunoassays that require long incubation times
(15–30 min)2,8 the microengine-induced localized convection
dramatically accelerates the binding process.
Additional control experiments were performed by using
diﬀerent assay formats to demonstrate that the surface-
conned antibody is solely responsible for the selective protein
isolation (see the ESI methods section for details). For example,
Fig. S3(A,a) and Video S4† (negative control 3) demonstrate that
an unmodied “control”microengine (without the immobilized
antibody) do not capture the IgG-B–anti-IgG-modied S-PP
complex, even aer multiple direct contacts. Furthermore, no
capture of the particle–protein complex was observed for
microtransporters without COOH groups (on the outermost
polymeric surface) that were incubated with the antibody
(Fig. S3(A,b)) and Video S4† (negative control 4).
An ‘on-the-y’ DASA assay of the protein mixture was
also carried out to conrm the high specicity of the1328 | Nanoscale, 2013, 5, 1325–1331surface-conned antibody towards the target protein. In such
microchip sandwich immunoassay the target protein is rst
captured from a mixture of proteins by the anti-IgG modied
microtransporters and later tagged with the S-PP tracer conju-
gated to the anti-IgG secondary antibody. The antibody-func-
tionalized motors and spheres were placed in two diﬀerent
reservoirs of the T-shaped LOC device, with the third reservoir
containing the 750 mg ml1 of free IgG protein target along with
a 10-fold excess of two other proteins, i.e., BSA and lysozyme
(Fig. 4). A modied microtransporter thus travels from the
modied-microengine reservoir (Fig. 4, 1) to the sample reser-
voir containing the protein mixture (Fig. 4, 2a); following a 10
min incubation while the microengine is continuously swim-
ming, it departs from the sample reservoir (Fig. 4, 2b and 3)
towards to the anti-IgG antibody reservoir (Fig. 4, 4). In this last
compartment, the captured target protein (on the micro-
transporter) binds to the secondary antibody-modied particle
(Fig. 4 and Video S5†), hence completing the microchip sand-
wich assay. These data clearly indicate the specic capture and
transport of the target protein, reecting the high aﬃnity of the
microtransporter surface antibody by the target protein and
the eﬀective minimization of non-specic binding due to the
blocking of the remaining surface amino moieties aer the
antibody functionalization. In addition, the peroxide fuel and
NaCh surfactant, essential for the microengine movement, do
not compromise the specic protein–antibody interaction or
the integrity of the bioreceptor coating.
The experimental reproducibility was investigated by using 8
diﬀerent batches of the modied microtransporters following
the identical processing steps. All the modied micro-
transporters were able to rapidly capture the S-PP-tagged-
targets, most oen immediately, upon few contacts. ThisThis journal is ª The Royal Society of Chemistry 2013
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View Article Onlineindicates that diﬀerent batches of modied transporters display
a high protein capture eﬃciency and demonstrates the reli-
ability of the fabrication, modication and movement steps
involved in the entire process. The fast recognition and binding
of the protein target indicates considerable promise for the
rapid, direct and real time isolation of proteins.
Direct protein detection was tested by examining the ability
of the antibody-modied microengines to recognize diﬀerent
quantities of the IgG target in the presence of a 10-fold excess of
BSA and lysozyme. Capture and transport of the IgG was
possible over the entire IgG concentration examined, i.e. from
20 to 750 mg ml1. Fig. S4 and the corresponding Video S6†
clearly illustrate that the functionalized microengines display
an immediate ‘on the y’ protein capture upon contacting the
tagged-antigen present at the 20 mg ml1 level, in the presence
of a 10-fold excess of BSA and lysozyme proteins.
The practical application of the new immunomicro-
transporter microchip approach was demonstrated also by the
label-free detection of Staphylococcus aureus target bacteria
(containing proteinA in its cell wall).29 As illustrated in Fig. 5
and Video S7,† an anti-proteinA antibody-modiedmicroengine
is able to recognize proteinA from the cell wall of Staphylococcus
aureus (S. aureus) while moving within the microchip. Fig. 5a–c
shows the modied microengine picking-up and loading this
small, round, Gram-positive UTI-related bacteria and further
leaving the reservoir containing the bacteria (Fig. 5d). The
bacteria dimension (around 2 mm) oﬀers convenient direct
optical visualization of the binding event. The specic binding
of the anti-proteinA-modied microengines to S. aureus was
also examined in PBS containing S. aureus target bacteria along
with a 5-fold excess Saccharomyces cerevisiae (S. cerevisiae), a
yeast specie frequently responsible for yeast infections and
UTIs. ESI, Fig. S5a–c and Video S7† demonstrate the selective
binding and transport of the small rod-shaped (2 mm length)
S. aureus bacteria (delineated by green dotted circles). In
contrast, the modied microengine does not capture the larger
round-shaped S. cerevisiae cells (5 mm in diameter) even when
multiple contacts occur (delineated by red dotted circles in the
video and ESI,† Fig. S5d–g). The distinctly diﬀerent size of the
target S. aureus and the S. cerevisiae control (2 mm vs. 5 mm,
respectively), allows a clear optical visualization of the selective
capture of the target cell and discrimination against non-targetFig. 5 Anti-ProtA-modiﬁed microtransporter approaching, contacting and
loading S. aureus cells within a LOC device containing PBS (a–d), and in a human
urine media containing bacteria (e–g), (experiments, on the surface of a glass
slide). The target bacteria is highlighted by orange circles.
This journal is ª The Royal Society of Chemistry 2013cells during the microengine movement (see Video S8†). Note
again that the similar size scale of the microengine and bacteria
facilitates such real-time visualization of the binding event (see
ESI, Fig. S5a–c and Video S8†). Such selective and rapid capture
event is attributed to the nearly instantaneous recognition of
the ProteinA molecules on the bacterial cell wall by the anti-
proteinA-modied microengine (ESI, Fig. S4a–c†). Finally,
capture and transport of the bacteria in an inoculated human
urine samples was also demonstrated, as shown in Fig. 5e–g
and ESI, Video S9.†Conclusions
We have demonstrated the rst example of microchip immu-
noassay protocols based on the movement of antibody-func-
tionalized synthetic microtransporters within microchannel
networks. New PEDOT:PEDOT–COOH/Ni/Pt immuno-micro-
engines have thus been used for an ‘on-the-y’ microchip DASA
involving antibody-functionalized microtransporters including
their directed capture and transport of target proteins along
predetermined paths in the LOC system. Compared to common
ELISA bioassays (in multiple well plates) the new motor-based
immunoassay allows replacement of the common washing
steps. Movement of the micrometer-size captured bacteria or
sphere tag thus oﬀer convenient direct real-time optical visu-
alization of the protein binding event. Using diﬀerent sizes of
the microsphere tracers opens up the possibility of developing
powerful chip-based multiplexed immunoassays involving
diﬀerent antibody-functionalized microtransporters. Such
autonomous transport of antibody-functionalized nanomotors
to ‘on-the-y’ capture and isolate target proteins obviates the
need for time-consuming and laborious multiple wash steps,
hence greatly simplifying and accelerating the whole immuno-
assay protocol. Whenever needed, common regeneration
procedures involving selected elution solutions,30,31 can be used
for releasing the captured antigen and re-using the micro-
engine. These results demonstrate the great potential of the
antibody-modied microengines for the selective recognition,
loading and isolation of target proteins and cells in a microchip
device. Self-propelled immuno-microengines are expected to
lead to new LOC bioanalytical microsystems with attractive
protein isolation and detection capabilities, thus oﬀering
numerous opportunities in diverse areas, ranging frommedical
diagnostics to food safety.Experimental section
Synthesis of multilayer microengines
The multilayer microtubes were prepared using a common
template directed electrodeposition protocol.28 A cyclopore
polycarbonate membrane, containing 2 mmmaximum diameter
conical-shaped micropores (Catalog no. 7060-2511; Whatman,
Maidstone, UK), was employed as a template. A 75 nm gold lm
was rst sputtered on one side of the porous membrane to serve
as a working electrode using a Denton Discovery 18. Sputtering
was performed at room temperature under vacuum of 5  106
Torr, DC power 200 W and Ar was owed at 3.1 mT. RotationNanoscale, 2013, 5, 1325–1331 | 1329
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View Article Onlinespeed was 65 rpm along with a sputtering time of 90 s. A Pt wire
and an Ag/AgCl with 3 M KCl were used as counter and refer-
ence electrodes, respectively. The membrane was then assem-
bled in a plating cell with an aluminum foil serving as contact
for the working electrode. PEDOT/PEDOT–COOH microtubes
were electropolymerized up to 0.5 C at +0.85 V from a plating
solution containing 7.5 mM of each monomer (EDOT and
EDOT–COOH), 100 mM SDS and 7.5 mMKNO3, all of them were
prepared from Sigma-Aldrich reagents. Then, the metallic layers
were deposited from a Pt–Ni mixture solution. The rst Pt layer
was deposited galvanostatically at 2 mA for 500 s to provide a
smooth and high conductive surface aer the polymer deposi-
tion and also improve the deposition of the next metallic layers.
Aerwards the intermediate Ni layer was deposited ampero-
metrically at1.3 V for 4.0 C to achieve the magnetic properties
that allow the micromotor guidance by properly orienting the
magnetic eld created by a simple neodymium magnet. Finally
the catalytic inner Pt layer was deposited galvanostatically at
2 mA for 450 s. The Pt–Ni mixture solution was prepared by
mixing the same volume of a commercial platinum solution
(Platinum RTP; Technic Inc, Anaheim, CA) and a Nickel solu-
tion containing a mixture of 20 g l1 NiCl2$6H2O, 515 g l
1
Ni(H2NSO3)2$4H2O, and 20 g l
1 H3BO3.
To release the microengines from the template, the sput-
tered gold layer was completely removed by mechanical hand
polishing with 3–4 mm alumina slurry. The membrane was then
dissolved in methylene chloride for 10 min to completely
release the microtubes. Finally, microengines were washed
repeatedly with methylene chloride, followed by ethanol and
ultrapure water (18.2 MU cm), three times of each, and collected
by centrifugation at 6000 rpm for 3 min aer each wash.
Microengines functionalization
1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC)/N-
hydroxysuccinimide (NHS) chemistry was used to activate the
carboxyl-terminated groups from the polymer for conjugation
with anti-Human IgG protein. For this purpose microengines
were treated with 200 ml of a 0.1 M MES buﬀer solution pH 5.0
containing 20 mg EDC and 20 mg NHS for 15 min, washed with
MES buﬀer 1 min and incubated with anti-Human IgG in PBS
1 pH 7.2 for 2 h. The excess of antibody were washed in PBS
buﬀer (1) pH 7.2 containing 0.05% of Tween 20. The
remaining amine reactive-esters from the activated carboxylic
groups were blocked with 1 M ethanolamine solution, pH 8.5,
for 30 min and BSA 1% for 1 hour with a washing step in
between in PBS 1 pH 7.2. In all the washing steps the micro-
engines were centrifuged at 6000 rpm for 4 min. All the exper-
iments were carried out under shaking at room temperature.
Streptavidin polystyrene particles
20 ml of streptavidin polystyrene particles were washed twice
with B&W buﬀer and then incubated in 50 ml of 400 mg ml1
biotin–anti-Human IgG antibody solution, for 15 min. The
excess of reagents was washed with Milli-Q water and particles
incubated with 50 ml IgG of 750 mg ml1 IgG antigen solution,
for 15 min. Finally the particles were washed with PBS buﬀer1330 | Nanoscale, 2013, 5, 1325–1331(1) pH 7.2 containing 0.05% of Tween 20 and then resus-
pended in 20 ml PBS buﬀer (1) for analysis.Equipment
Template electrochemical deposition of microtube was carried
out with a CHI 661D potentiostat (CH Instruments, Austin, TX).
An inverted optical microscope (Nikon Eclipse Instrument Inc.
Ti-S/L100), coupled with a 20 objective, along with a Hama-
matsu digital camera C11440 and a NIS-Elements AR 3.2 so-
ware, were used for capturing movies at a frame rate of 20
frames per second. The speed of the microengines was tracked
using a NIS-Elements tracking module and the results were
statistically analyzed by using Origin soware.Experimental procedure
Self-propelled catalytic microengines in the microchannel were
operated by lling the reservoirs and microchannel with a
navigating solution consisting of a 2% NaCh/1% H2O2 mixture
in PBS buﬀer solution (pH 7.2). Subsequently, microengines
and particles were added into the reservoirs and were equili-
brated until quiescent conditions were obtained. The move-
ment of the microengines and all tasks were captured using the
inverted optical microscope. Small quantities of either surfac-
tant or fuel were further added when necessary. Such addition
ensures not only the autonomous navigation of the micro-
engines over prolonged time periods but also the absence of
solution ow during the experiments (by maintaining the
volume of mixture contained in the reservoirs).Acknowledgements
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